SOLENO THERAPEUTICS INC - COMMON STOCK (SLNO)

CUSIP: 834203309

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class
Equity / COMMON STOCK
Shares outstanding
51,293,400
Total 13F shares
2,785,956
Share change
+13,301
Total reported value
$5,517,109
Put/Call ratio
0%
Price per share
$1.98
Number of holders
22
Value change
+$81,616
Number of buys
13
Number of sells
6

Security key

834203309

Report period

Q4 2022

Institutions

22

Top holders

10

Top shareholders of SLNO - SOLENO THERAPEUTICS INC - COMMON STOCK (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
Holder Source Role / Reporting Ownership % Shares Holdings Value 12M Net Δ As of Details
Abingworth LLP
3/4/5 13F
10%+ Owner · Company
2.3%
from 13F
25,774,464
mixed-class rows
$657,560,041 21 Dec 2018
Nantahala Capital Management, LLC
13F
Company
1.2%
604,179
$1,009,000 30 Sep 2022
13F
AIGH Capital Management LLC
13F
Company
0.83%
424,089
$708,000 30 Sep 2022
13F
Granite Point Capital Management, L.P.
13F
Company
0.34%
176,456
$295,000 30 Sep 2022
13F
VANGUARD GROUP INC
13F
Company
0.24%
121,086
$202,000 30 Sep 2022
13F
Worth Venture Partners, LLC
13F
Company
0.21%
105,513
$176,000 30 Sep 2022
13F
J. Goldman & Co LP
13F
Company
0.09%
44,999
$75,000 30 Sep 2022
13F
RENAISSANCE TECHNOLOGIES LLC
13F
Company
0.09%
44,954
$75,000 30 Sep 2022
13F
GEODE CAPITAL MANAGEMENT, LLC
13F
Company
0.06%
32,556
$54,000 30 Sep 2022
13F
STATE STREET CORP
13F
Company
0.03%
15,448
$26,000 30 Sep 2022
13F
BNP PARIBAS FINANCIAL MARKETS
13F
Company
0.02%
9,333
$15,586 30 Sep 2022
13F
Tower Research Capital LLC (TRC)
13F
Company
0%
862
$1,000 30 Sep 2022
13F
MORGAN STANLEY
13F
Company
0%
649
$1,000 30 Sep 2022
13F
GROUP ONE TRADING LLC
13F
Company
0%
358
$1,000 30 Sep 2022
13F
Jack W. Schuler
3/4/5
10%+ Owner
class O/S missing
36,595
$1,335,180 09 Dec 2022
Birchview Capital, LP
13F
Company
class O/S missing
245,127
$409,000 30 Sep 2022
13F
Clayton Partners LLC
13F
Company
class O/S missing
100,000
$167,000 30 Sep 2022
13F
Bollard Group LLC
13F
Company
class O/S missing
2,288
$4,000 30 Sep 2022
13F

Institutional Holders of SOLENO THERAPEUTICS INC - COMMON STOCK (SLNO) as of Q4 2022

As of 31 Dec 2022, SOLENO THERAPEUTICS INC - COMMON STOCK (SLNO) was held by 22 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,785,956 shares. The largest 10 holders included Abingworth LLP, Nantahala Capital Management, LLC, AIGH Capital Management LLC, J. Goldman & Co LP, Worth Venture Partners, LLC, Clayton Partners LLC, VANGUARD GROUP INC, RENAISSANCE TECHNOLOGIES LLC, MILLENNIUM MANAGEMENT LLC, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 22 institutional shareholders reporting positions in this security for the Q4 2022 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period

Compare Q4 2022 vs Q3 2022 Across Filers

Q3 2022 holders
14
Q4 2022 holders
22
Holder diff
8
Investor Q3 2022 Shares Q4 2022 Shares Share Diff Share Chg % Q3 2022 Value $ Q4 2022 Value $ Value Diff $ Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Here you can make detailed settings or revoke your consent (in part if necessary) with effect for the future. For further information, please refer to our Privacy Policy .